Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hemostats Market Set To Climb From $3.8 Billion In 2026 To $5.02 Billion By 2030
The hemostats market has experienced significant expansion recently. Its size is projected to increase from $3.56 billion in 2025 to $3.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this market growth can be linked to factors such as a rise in surgical procedure volume, the expansion of hospital surgical infrastructure, advancements in biomaterial technologies, a heightened demand for effective blood loss management, and the broader acceptance of minimally invasive surgeries.
The hemostats market size is anticipated to undergo significant expansion in the upcoming years. It is forecast to grow to $5.02 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.2%. This projected growth during the forecast period can be attributed to an elevated focus on patient safety outcomes, increasing demand for faster surgical recovery, the expansion of advanced trauma care facilities, ongoing innovation in bioactive hemostatic materials, and a greater adoption of specialty surgical products. Key trends expected in the forecast period encompass the increasing utilization of advanced combination hemostats, a rising acceptance of ready-to-use hemostatic agents, a growing need for rapid bleeding control solutions, the proliferation of biocompatible and absorbable products, and an intensified concentration on surgical efficiency and safety.
Get A Free Sample Report With In-Depth Market Insights:
Hemostats Market Growth Factors: What’s Supporting Expansion?
The hemostat market is projected to expand due to a rise in surgical procedures. These procedures encompass all invasive medical interventions performed on a person to diagnose or remedy an illness. Hemostats are crucial in surgery because they prevent excessive bleeding during operations. For example, the American Society of Plastic Surgeons, a US-based non-profit organization, reported in June 2024 that minimally invasive procedures increased by 7% in 2023, outpacing the general growth rate of surgical procedures by 2%. Hand surgeries, such as carpal tunnel, arthritis, and trigger finger, totaled 207,887 procedures, marking a 2% rise from 2022. Consequently, the expanding volume of surgical procedures is fueling the hemostat market’s growth. A growing incidence of trauma cases is anticipated to drive the haemostat market’s expansion in the future. A trauma case denotes any medical scenario where injury, resulting from an external force, necessitates immediate assessment and care. The surge in trauma cases stems from more road accidents, where greater traffic volume and risky driving behaviors result in serious injuries needing prompt medical attention. Hemostats assist in trauma situations by quickly managing bleeding at the wound site, enabling medical professionals to stabilize patients faster and enhance survival rates. For instance, the Alaska Department of Health, a US-based government agency, reported in October 2024 that roughly 3,373 individuals in Alaska suffered traumatic brain injuries (TBI) in 2023, encompassing both fatal instances and non-fatal injuries managed and discharged from hospitals or emergency departments (EDs). Consequently, the rising occurrence of trauma cases is fueling the growth of the haemostat market.
Hemostats Market Segment Trends And Revenue Contributors
The hemostats market covered in this report is segmented –
1) By Composition: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats
2) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats, Other Products
3) By Formulation: Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats
4) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications
Subsegments:
1) By Thrombin-Based Hemostats: Topical Thrombin, Lyophilized Thrombin
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads, Granules
3) By Combination Hemostats: Thrombin And Gelatin Combinations, Thrombin And Collagen Combinations
4) By Gelatin-Based Hemostats: Gelfoam, Gelatin Sponge
5) By Collagen-Based Hemostats: Collagen Sheets, Collagen Powder
Hemostats Market Industry Trends: What’s Reshaping Demand?
Leading companies in the Hemostat market are strategically forming partnerships and collaborations with startups and mid-sized firms to expand their range of products and services. These strategic collaborations and partnership agreements assist companies in broadening their current product portfolios and geographical footprints. For instance, in May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, strengthened its Endoclot partnership with Endoclot, a US-based medical device company, to introduce hemostatic agents. Incorporating these solutions into its portfolio allows Olympus to support safe treatment in gastrointestinal procedures. The objective of this partnership is to improve patient outcomes and, in doing so, elevate the standard of care.
Hemostats Market Company Landscape And Competitive Strategy
Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom’up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc.
View The Full Hemostats Market Report:
Hemostats Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
